242 related articles for article (PubMed ID: 25726162)
1. Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics.
Plazinska A; Plazinski W; Jozwiak K
Eur Biophys J; 2015 Apr; 44(3):149-63. PubMed ID: 25726162
[TBL] [Abstract][Full Text] [Related]
2. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
Plazinska A; Kolinski M; Wainer IW; Jozwiak K
J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
[TBL] [Abstract][Full Text] [Related]
3. Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand.
Toll L; Pajak K; Plazinska A; Jozwiak K; Jimenez L; Kozocas JA; Tanga MJ; Bupp JE; Wainer IW
Mol Pharmacol; 2012 Jun; 81(6):846-54. PubMed ID: 22434858
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective binding of agonists to the β
Plazinska A; Plazinski W
Mol Biosyst; 2017 May; 13(5):910-920. PubMed ID: 28338133
[TBL] [Abstract][Full Text] [Related]
6. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol.
Beigi F; Bertucci C; Zhu W; Chakir K; Wainer IW; Xiao RP; Abernethy DR
Chirality; 2006 Nov; 18(10):822-7. PubMed ID: 16917835
[TBL] [Abstract][Full Text] [Related]
8. Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes.
Pönicke K; Gröner F; Heinroth-Hoffmann I; Brodde OE
Br J Pharmacol; 2006 Apr; 147(7):714-9. PubMed ID: 16474418
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
10. Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor.
Bhattacharya S; Vaidehi N
J Am Chem Soc; 2010 Apr; 132(14):5205-14. PubMed ID: 20235532
[TBL] [Abstract][Full Text] [Related]
11. Ligand entry and exit pathways in the beta2-adrenergic receptor.
Wang T; Duan Y
J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
[TBL] [Abstract][Full Text] [Related]
12. Effect of fenoterol stereochemistry on the β2 adrenergic receptor system: ligand-directed chiral recognition.
Jozwiak K; Plazinska A; Toll L; Jimenez L; Woo AY; Xiao RP; Wainer IW
Chirality; 2011; 23 Suppl 1(Suppl 1):E1-6. PubMed ID: 21618615
[TBL] [Abstract][Full Text] [Related]
13. Membrane-Facilitated Receptor Access and Binding Mechanisms of Long-Acting
Szlenk CT; Gc JB; Natesan S
Mol Pharmacol; 2021 Oct; 100(4):406-427. PubMed ID: 34334369
[TBL] [Abstract][Full Text] [Related]
14. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
Yuzlenko O; Kieć-Kononowicz K
J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
[TBL] [Abstract][Full Text] [Related]
16. Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.
Jozwiak K; Khalid C; Tanga MJ; Berzetei-Gurske I; Jimenez L; Kozocas JA; Woo A; Zhu W; Xiao RP; Abernethy DR; Wainer IW
J Med Chem; 2007 Jun; 50(12):2903-15. PubMed ID: 17506540
[TBL] [Abstract][Full Text] [Related]
17. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
Reynolds KA; Katritch V; Abagyan R
J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
[TBL] [Abstract][Full Text] [Related]
18. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors.
Uberti MA; Hague C; Oller H; Minneman KP; Hall RA
J Pharmacol Exp Ther; 2005 Apr; 313(1):16-23. PubMed ID: 15615865
[TBL] [Abstract][Full Text] [Related]
19. Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules.
Gandhimathi A; Sowdhamini R
J Biomol Struct Dyn; 2016 May; 34(5):952-70. PubMed ID: 26327576
[TBL] [Abstract][Full Text] [Related]
20. Fast, metadynamics-based method for prediction of the stereochemistry-dependent relative free energies of ligand-receptor interactions.
Plazinska A; Plazinski W; Jozwiak K
J Comput Chem; 2014 Apr; 35(11):876-82. PubMed ID: 24615679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
